Table 4.
Study Number | Vitamin D Assessment | Outcomes | Risk Factors |
---|---|---|---|
Alvim-Pereira et al. [21] | NR | 9.8% implant loss rate | No association between Vitamin D TaqI receptor polymorphism and implant loss. |
Flanagan et al. [22] | Vitamin D3 supplementation, phosphate binders and calcium cinacalcet calcimimetic, 3 × dialysis/week | Successful implantation | Low serum Vitamin D levels do not pose an elevated risk for loss of dental implant if calcium levels are properly corrected in patients with IgA nephropathy. |
Bryce et al. [23] | Severe Vitamin D deficiency | Successful implantation | Low serum Vitamin D might contribute to unsuccessful osseointegration in dental implants. |
Fretwurst et al. [24] | Vitamin D deficiency | 22.2% implant loss rate | Successful replacement after Vitamin D supplementation |
Mangano et al. [25] | Vitamin D deficiency in 53.7% of patients; 29.5 ng/mL vs. 25.4 ng/mL in the early failure group | 3.9% implant loss rate; 11.1% among patients with severe vitamin D deficiency | Four times higher prevalence of early implant loss with low serum Vitamin D levels; higher when associated with smoking and periodontal disease. |
Pereira et al. [26] | Vitamin D deficiency due to receptor mutation | 11.4% implant loss rate | Vitamin D allele G of rs3782905 significantly associated with poor osseointegration. |
Kwiatek et al. [27] | Day of surgery: 23.9 ng/mL, After 6 weeks: 30.4 ng/mL, After 12 weeks: 33.1 ng/mL | NR | Significantly higher bone density in patients with Vitamin D supplementation after 12 weeks. |
NR—not reported; OR—odds ratio. Vitamin D hypovitaminosis (insufficiency) is considered below 20 ng/mL or 50 nmol/L; vitamin D deficiency is considered below 10 ng/mL or 25–30 nmol/L; severe deficiency is considered for levels below 10 nmol/L.